ARTICLE | Company News
Cerulean management update
November 3, 2014 8:00 AM UTC
Cerulean Pharma Inc. (NASDAQ:CERU), Cambridge, Mass. Business: Drug delivery, Cancer Resigned: Oliver Fetzer as president, CEO and a director Transitioned: CBO Chris Guiffre to COO ...